PWM
VTYX

Palumbo Wealth Management’s Ventyx Biosciences VTYX Stock Holding History

Palumbo Wealth Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,270
Closed -$58.4K – 224
2025
Q2 		$58.4K Buy
27,270
+772
+3% +$1.25K 0.02% 196
2025
Q1 		$30.5K Buy
26,498
+2,566
+11% +$4.41K 0.01% 186
2024
Q4 		$52.4K Buy
23,932
+11,792
+97% +$26.7K 0.02% 173
2024
Q3 		$26.5K Buy
+12,140
New +$27.9K 0.01% 157

Other funds holding VTYX

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Palumbo Wealth Management's VTYX Position: Q3 2025 in Review

Palumbo Wealth Management sold out of Ventyx Biosciences (VTYX) in Q3 2025, closing a stake of 27,270 shares — an estimated $58.4K sold.

Palumbo Wealth Management first reported a position in VTYX in Q3 2024 and held it in 4 quarters. The position peaked at $58.4K in Q2 2025. 110 funds tracked by Wall St. Rank hold VTYX as of Q3 2025.

  • Palumbo Wealth Management reported no remaining Ventyx Biosciences position as of Q3 2025 after selling out during the quarter.
  • Palumbo Wealth Management sold 27,270 Ventyx Biosciences shares in Q3 2025, an estimated $58.4K.
  • Palumbo Wealth Management first reported a position in Ventyx Biosciences in Q3 2024 and held it in 4 quarters.
  • Palumbo Wealth Management's Ventyx Biosciences position peaked at $58.4K in Q2 2025.
  • 110 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q3 2025.

Based on Palumbo Wealth Management's 13F filing for Q3 2025, filed 10 Nov 2025.